Atlas Trials

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Clinical trial NCT01880515 · COMPLETED

Trial details

NCT number
NCT01880515
Sponsor
Instituto Nacional de Cancerologia de Mexico
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Skin RashLung Cancer
Start date
2010-12-01
Primary completion
2014-07-01
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.